Company Filing History:
Years Active: 2020-2024
Title: The Innovations of Won-Ki Huh
Introduction
Won-Ki Huh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research through his innovative work on G protein-coupled receptor (GPCR) heteromers. With a total of 2 patents, his inventions are paving the way for new therapeutic approaches in oncology.
Latest Patents
One of Won-Ki Huh's latest patents focuses on GPCR heteromer inhibitors and their uses. This invention pertains to inhibitors of CXC receptor 4 (CXCR4)-G protein-coupled receptor (GPCR) heteromers associated with cancers. Specifically, it addresses how CXCR4 forms a functional heteromer with other GPCRs, leading to enhanced signaling when co-stimulated with CXCR4 and GPCR agonists. The invention also includes the use of inhibitors targeting the interacting GPCR partner of the CXCR4-GPCR heteromer, which can be utilized in the diagnosis and therapy for cancer.
Career Highlights
Won-Ki Huh is currently associated with GPCR Therapeutics, Inc., where he continues to advance his research in GPCR-related therapies. His work is instrumental in developing new strategies for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
He collaborates with notable colleagues such as DongSeung Seen and Eunhee Kim, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Won-Ki Huh's contributions to the field of cancer research through his patents on GPCR heteromer inhibitors highlight his role as a leading inventor. His work not only enhances our understanding of cancer biology but also opens new avenues for therapeutic interventions.